Research method
Blinding and Placebo Control
4 studies
Blinding means some people in a study — patients, clinicians, or outcome assessors — do not know which arm was assigned. Placebo control means the comparator is an inert look-alike so that expectancy and attention are held roughly equal. Those two devices are related but not identical: a data collector can be blinded in an app-versus-usual-care trial that has no dummy pill, and a diagnostic PPG study can use ECG as a reference without blinding anyone to a treatment. The method tag in this library therefore names a family of validity threats, not one shared protocol.
Readers reach for blinding and placebo language when they need to know whether a reported benefit could be expectancy, extra contact, or knowledge of assignment. It answers 'who knew, and what was the comparator made of?' Its main limitation here is mismatch: one paper blinded collectors in a parenting-app RCT, one is an adherence substudy inside a placebo-controlled PrEP trial, one is an open child-care programme trial, and one is a diagnostic accuracy study. Treating all four as placebo RCTs is the characteristic error.
Studies
4
Findings
4
4 supporting · 0 challenging · 0 qualifying citations
Open tensions
1
Currently
What we know
- A technology-based supportive educational parenting programme randomised 118 couples (236 parents) versus standard care. At 3 months, intervention parents had better bonding and parenting satisfaction and lower postnatal depression and anxiety scores; benefits emerged by 1–3 months rather than immediately postpartum. The data collector was blinded to assignment, but parents still received an identifiable programme rather than a placebo app, so expectancy is not fully closed.
- At three Partners PrEP sites, 1,147 HIV-uninfected partners had unannounced pill counts and MEMS monitoring, with stepped counselling when UPC adherence fell below 80%. Median adherence was 99.1% (UPC) and 97.2% (MEMS); among those triggered, 92% returned to ≥80% UPC after sessions. Those figures describe intensively monitored trial adherence, including in a placebo-controlled parent study, not routine-clinic PrEP taking.
- Child-care centres in three US states were randomised to nurse-coach nutrition and physical-activity improvements versus control. Among 552 children and 137 providers, the intervention-versus-control difference in mean zBMI change was significant (coefficient −0.14; p=0.02). Centre-level assignment with socioeconomic imbalances and a short, unblinded behavioural programme is not a placebo-fed feeding trial.
- FibriCheck PPG was compared with 12-lead ECG in primary care (241 enrolled, 223 analysed), yielding sensitivity 95.6% and specificity 96.6% after excluding pacing and poor signals. That is agreement with a reference standard, not a blinded placebo-controlled treatment trial. PPV and NPV still depend on prevalence.
Largest unresolved question
Who is blinded, and whether a placebo exists, disagrees across the four papers. SEPP blinded the collector while comparing an identifiable parenting programme with standard care. Partners PrEP adherence work sits inside a placebo-controlled antiretroviral trial but reports UPC/MEMS adherence (99.1%/97.2%), not a placebo-subtracted efficacy estimate. The child-care zBMI trial is an open cluster-style programme contrast. FibriCheck does not assign a treatment at all. One method label is doing four jobs.
Common misconceptions
If a paper is indexed under blinding and placebo, patients received dummy pills.
Only the Partners PrEP context is a placebo-controlled prevention trial; this paper is an adherence substudy (median UPC 99.1%). SEPP compared a real programme with standard care and blinded the collector. The child-care trial compared coach-supported centres with control. FibriCheck compared PPG with ECG.
Collector blinding makes self-reported postnatal mood scores immune to expectancy.
SEPP's blinded assessor reduces observer bias in how scores are recorded. Parents still knew they received a technology programme, and PND/PNA and bonding are parent-reported. Benefits at 3 months versus standard care can still include attention and expectancy.
99.1% PrEP adherence in a monitored substudy is what routine clinics should expect, and diagnostic accuracy versus ECG is a form of placebo control.
Unannounced counts, MEMS and stepped counselling when UPC fell below 80% are intensive trial procedures; 92% of triggered partners recovered to ≥80%, which may not generalise. FibriCheck's 95.6%/96.6% figures are test-versus-reference agreement, not a sham-device treatment effect.
Related
Claim ledger
What the evidence shows
Drawn from 4 studies in this library. Mix labels say which citation roles are present; they are not a strength score. Supports means evidence for a finding; Challenges means evidence against a stated position; Qualifies marks scope.
A technology-based supportive educational parenting programme randomised 118 couples (236 parents) versus standard care. At 3 months, intervention parents had better bonding and parenting satisfaction and lower postnatal depression and anxiety scores; benefits emerged by 1–3 months rather than immediately postpartum. The data collector was blinded to assignment, but parents still received an identifiable programme rather than a placebo app, so expectancy is not fully closed.
At three Partners PrEP sites, 1,147 HIV-uninfected partners had unannounced pill counts and MEMS monitoring, with stepped counselling when UPC adherence fell below 80%. Median adherence was 99.1% (UPC) and 97.2% (MEMS); among those triggered, 92% returned to ≥80% UPC after sessions. Those figures describe intensively monitored trial adherence, including in a placebo-controlled parent study, not routine-clinic PrEP taking.
Child-care centres in three US states were randomised to nurse-coach nutrition and physical-activity improvements versus control. Among 552 children and 137 providers, the intervention-versus-control difference in mean zBMI change was significant (coefficient −0.14; p=0.02). Centre-level assignment with socioeconomic imbalances and a short, unblinded behavioural programme is not a placebo-fed feeding trial.
FibriCheck PPG was compared with 12-lead ECG in primary care (241 enrolled, 223 analysed), yielding sensitivity 95.6% and specificity 96.6% after excluding pacing and poor signals. That is agreement with a reference standard, not a blinded placebo-controlled treatment trial. PPV and NPV still depend on prevalence.
Debates
Tensions and limits
Some items are genuine disagreements on the same question. Others mark different assays, populations, or outcomes.
Who is blinded, and whether a placebo exists, disagrees across the four papers. SEPP blinded the collector while comparing an identifiable parenting programme with standard care. Partners PrEP adherence work sits inside a placebo-controlled antiretroviral trial but reports UPC/MEMS adherence (99.1%/97.2%), not a placebo-subtracted efficacy estimate. The child-care zBMI trial is an open cluster-style programme contrast. FibriCheck does not assign a treatment at all. One method label is doing four jobs.
Who is blinded, and whether a placebo exists, disagrees across the four papers. SEPP blinded the collector while comparing an identifiable parenting programme with standard care. Partners PrEP adherence work sits inside a placebo-controlled antiretroviral trial but reports UPC/MEMS adherence (99.1%/97.2%), not a placebo-subtracted efficacy estimate. The child-care zBMI trial is an open cluster-style programme contrast. FibriCheck does not assign a treatment at all. One method label is doing four jobs.
- Tech parenting program cut postpartum distress
- PrEP adherence in Partners PrEP
- Child-care diet/activity RCT and zBMI
- Smartphone PPG to detect atrial fibrillation
Study Role Design N Population Outcome Tech parenting program cut postpartum distress Supports RCTTechnology-based SEPP vs standard care through 3 months postpartum N=236 · 118 couples; 59 couples per arm Couples (mothers and fathers) enrolled in a supportive educational parenting program Parental bonding, PND, PNA, and parenting satisfaction at 3 months PrEP adherence in Partners PrEP Supports CohortPartners PrEP adherence substudy with UPC, MEMS, and stepped counseling N=1147 · HIV-uninfected partners at three East African sites HIV-uninfected partners in serodiscordant couples on PrEP within a clinical trial Pill-count and MEMS adherence, and return to ≥80% after counseling Child-care diet/activity RCT and zBMI Supports RCTCluster RCT of nurse coach-supported nutrition/PA improvements in child care centres vs control N=552 · 552 children aged 3–5 and 137 providers across CA, CT, and NC; seven-month trial Preschool children in US child care centres Change in child zBMI Smartphone PPG to detect atrial fibrillation Supports Cross-sectionalDiagnostic accuracy vs 12-lead ECG in primary care N=223 · 241 enrolled; 223 analysed after exclusions Primary-care patients screened for atrial fibrillation with FibriCheck PPG Sensitivity and specificity of mobile PPG for AF vs 12-lead ECG
PaperFren reads this as a limit on how far one study travels — different assays, populations, or outcomes — not a forced fight between papers.
Timeline
How understanding moved
Study years are when the paper was published. Evidence edits are dated changes to this page's claims. Explanations are when PaperFren added a Discovery — not a claim that the science happened that day.
2026
Concept page published
Blinding and Placebo Control
Change log
What changed
Dated edits to this page's evidence: studies added or removed from a claim, claims added or withdrawn, and new explanations tagged here. Coverage edits are distinct from reviewed research changes and corrections. Dates record PaperFren updates; study publication dates appear in the timeline.
- Coverage updated · Concept page published
Papers
4 studies in this library bear on Blinding and Placebo Control, ordered by citations.
- PrEP adherence in Partners PrEP
In a Partners PrEP adherence substudy, median pill-count and MEMS adherence exceeded 97%, and counseling restored most low adherers to ≥80%.
- Smartphone PPG to detect atrial fibrillation
FibriCheck PPG showed ~96% sensitivity and specificity versus cardiologist ECG on analysable traces.
- Child-care diet/activity RCT and zBMI
A seven-month child-care nutrition and activity intervention significantly reduced children's zBMI versus control centers.
- Tech parenting program cut postpartum distress
A Singapore RCT found a technology-based supportive educational parenting program improved bonding and satisfaction while reducing postnatal depression and anxiety.
Compare studies
Select 2–10 studies. Design and N are labels, not a ranking.
Nothing selected yet.
Questions
What is still open
Who is blinded, and whether a placebo exists, disagrees across the four papers. SEPP blinded the collector while comparing an identifiable parenting programme with standard care. Partners PrEP adherence work sits inside a placebo-controlled antiretroviral trial but reports UPC/MEMS adherence (99.1%/97.2%), not a placebo-subtracted efficacy estimate. The child-care zBMI trial is an open cluster-style programme contrast. FibriCheck does not assign a treatment at all. One method label is doing four jobs.
Ask PaperFren about Blinding and Placebo Control
Study this conceptflashcards and short-answer questions
SEPP reports lower PND and PNA at 3 months with a blinded data collector. What did blinding protect, and what did it not?
It protected against the recorder knowing assignment when scores were taken. It did not make the trial placebo-controlled: 118 couples received a visible technology programme or standard care, and mood and bonding are parent-reported, so expectancy and extra support remain plausible contributors.
Why are Partners PrEP's median 99.1% UPC and 97.2% MEMS figures a weak basis for assuming routine-clinic adherence, even though the parent trial used placebo?
The substudy of 1,147 partners used unannounced counts, electronic monitors and extra counselling below 80% UPC (92% recovered). High adherence under that surveillance, in a trial that also included placebo, is not the same as unmonitored clinic PrEP taking.
The child-care trial's zBMI coefficient was −0.14 (p=0.02) among 552 children. Which validity threats would a placebo or tighter blinding have been aimed at, and did this design have them?
Expectancy, extra coaching attention, and knowledge of assignment among providers and families. Centres were randomised to a visible nurse-coach programme versus control, with socioeconomic imbalances and short follow-up — an open behavioural contrast, not a blinded placebo diet.
A student files FibriCheck under 'placebo-controlled because there was a gold-standard comparison.' What is the correct design name?
Diagnostic accuracy against 12-lead ECG (sensitivity 95.6%, specificity 96.6% in 223 analysed patients), after excluding pacing and poor signals. A reference standard is not a placebo treatment, and PPV/NPV still depend on AF prevalence.